Skip to main content
Biogened Spolka Akcyjna logo

Biogened Spolka Akcyjna — Investor Relations & Filings

Ticker · BGD ISIN · PLBIOGN00018 LEI · 259400JPC8O2DFHO9887 WAR Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2026-05-29 Governance Information
Country PL Poland
Listing WAR BGD

About Biogened Spolka Akcyjna

http://www.biogened.pl

Biogened Spolka Akcyjna is a pharmaceutical company that develops, produces, and distributes dermo-cosmetics, dietary supplements, and medical products. The company's core focus is on its flagship brand, Dermedic, which provides specialized preparations for the care of sensitive and problematic skin. Leveraging extensive pharmaceutical knowledge and close collaboration with dermatologists, Biogened creates innovative, patent-protected solutions. Product formulations are based on unique compositions of active ingredients and incorporate the latest global trends and technologies in dermatology. The company's products are available in numerous international markets.

Recent filings

Filing Released Lang Actions
zal12_Uchwala_Zarzadu_Nr_20_pelnomocnictwo_w_postaci_elektronicznej.pdf
Governance Information Classification · 85% confidence The document is a management board resolution (Uchwała) establishing the internal procedure for notifying the company electronically about granting electronic proxies for voting at the upcoming Annual General Meeting. It sets out corporate governance rules rather than announcing management changes, financial results, or publishing a report. This aligns with the definition of a Governance Information filing (CGR).
2026-05-29 Polish
zal08_Formularz_dla_osoby_innej_niz_osoba_fizyczna_-_zgloszenie_projektu_uchwaly.pdf
Proxy Solicitation & Information Statement Classification · 72% confidence The document is a form for shareholders to submit draft resolutions to be included on the agenda of Biogened S.A.’s Ordinary General Meeting (zwyczajne walne zgromadzenie). It is part of the pre-meeting materials directed to shareholders, providing instructions and requirements for putting items on the AGM agenda, and solicits shareholder action. This aligns with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to inform them about meeting matters and request their votes or inputs.
2026-05-29 Polish
zal10_Formularz_dla_osoby_innej_niz_osoba_fizyczna_-_wniosek_o_umieszczenie_sprawy_w_porzadku_obrad.pdf
Regulatory Filings Classification · 72% confidence The document is a shareholder’s formal request to include items and draft resolutions on the agenda of the company’s upcoming Annual General Meeting (Zwyczajne Walne Zgromadzenie). It is not the annual report, proxy statement, voting results, or AGM presentation materials, but rather a procedural filing form. It does not present financials or serve as a report itself. It therefore best fits under the fallback category for miscellaneous regulatory/compliance filings.
2026-05-29 Polish
zal13_Formularz_dla_osoby_fizycznej_-_zgloszenie_projektu_uchwaly.pdf
Regulatory Filings Classification · 55% confidence The document is a shareholder’s submission form (“ZGŁOSZENIE PROJEKTU UCHWAŁY”) to propose a draft resolution for inclusion on the agenda of the ordinary general meeting of Biogened S.A. It is not the AGM materials themselves, nor a proxy statement, nor any financial report. It is a procedural regulatory form, so it falls into the miscellaneous regulatory filings category.
2026-05-29 Polish
zal04_Formularz_dla_osoby_fizycznej_-_wniosek_o_umieszczenie_sprawy_w_porzadku_obrad.pdf
AGM Information Classification · 85% confidence The document is a shareholder’s written request (in Polish) to include a matter and draft resolution on the agenda of the upcoming Ordinary General Meeting (Walne Zgromadzenie). It is not the Annual Report itself, nor financial statements, nor a call transcript or proxy solicitation. It is part of the AGM procedural materials, thus falls under AGM Information (AGM-R).
2026-05-29 Polish
zal03_FORMULARZ_do_wykonywania_prawa_glosu_przez_pelnomocnika.pdf
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a proxy voting form (“formularz do wykonywania prawa głosu przez pełnomocnika”) for the Annual General Meeting of Biogened S.A. on June 25, 2026, containing voting instructions on agenda items. This is not an announcement of results or a financial report, but part of the proxy materials sent to shareholders to solicit votes. This fits under “Proxy Solicitation & Information Statement” (PSI).
2026-05-29 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.